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Abstract
Background: More information is often thought to improve medical decision-making, which may lead to test
overuse. This study assesses which out of 15 laboratory tests contribute to diagnosing the underlying cause of
anaemia by general practitioners (GPs) and determines a potentially more efficient subset of tests for setting the
correct diagnosis.
Methods: Logistic regression was performed to determine the impact of individual tests on the (correct) diagnosis.
The statistically optimal test subset for diagnosing a (correct) underlying cause of anaemia by GPs was determined
using data from a previous survey including cases of real-world anaemia patients.
Results: Only 9 (60%) of the laboratory tests, and patient age, contributed significantly to the GPs’ ability to diagnose
an underlying cause of anaemia (CRP, ESR, ferritin, folic acid, haemoglobin, leukocytes, eGFR/MDRD, reticulocytes and
serum iron). Diagnosing the correct underlying cause may require just five (33%) tests (CRP, ferritin, folic acid, MCV and
transferrin), and patient age.
Conclusions: In diagnosing the underlying cause of anaemia a subset of five tests has most added value. The real-
world impact of using only this subset should be further investigated. As illustrated in this case study, a statistical
approach to assessing the added value of tests may reduce test overuse.
Keywords: Anemia, Data analysis, statistical, Diagnoses and laboratory examinations, General practice, Optimal testing,
Overuse
Background
In the last decades there has been a strong rise in the
number of relatively cheap laboratory tests that are avail-
able as well as in the number of tests requested by physi-
cians [1, 2]. These developments provide challenges to
physicians with regard to determining which tests to
order and how to interpret their combined results [3–5].
This issue is particularly relevant for general practi-
tioners (GPs) as they order a large variety of laboratory
tests during ~ 30% of all patient encounters [3, 4]. Al-
though these challenges are partly unavoidable owing to
the large variability of symptoms encountered within
general practices [6], GPs may benefit from improved
guidance as to which tests to order in which patients.
Besides the benefits of laboratory testing in terms of set-
ting a diagnosis and deciding upon the best treatment
strategy, these tests may offer wider benefits to patients,
for example in terms of reducing diagnostic uncertainty or
offering reassurance [6–8]. However, laboratory testing is
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: m.m.a.kip@utwente.nl
†Michelle M. A. Kip and Martijn L. J. Oonk contributed equally to this work.
1Department of Health Technology and Services Research, University of
Twente, Technical Medical Center, Faculty of Behavioural, Management and
Social Sciences, Enschede, the Netherlands
Full list of author information is available at the end of the article
Kip et al. BMC Medical Informatics and Decision Making          (2020) 20:178 
https://doi.org/10.1186/s12911-020-01198-8
(inevitably) also associated with patient discomfort, and a
plethora of test results may divert the physician’s attention
away from the clinically relevant information [9]. In
addition, it may lead to overdiagnosis, which may result in
unnecessary, potentially harmful or costly downstream ac-
tivities [10–14]. Indeed, previous studies suggest that, de-
pending on the definition used, 30–70% of all laboratory
tests may be considered potentially inappropriate [6, 15,
16]. In this study, ‘overutilization’ of tests is defined as per-
forming tests that do not affect medical decision-making
[16, 17].
To investigate the added diagnostic value of tests for
decision-making, a case study of patients presenting with
anaemia in general practice is used. Anaemia is a fre-
quently encountered condition in general practice and is
characterized by a low blood haemoglobin level. Its inci-
dence increases with age, and it is associated with in-
creased morbidity and mortality [18–25]. However, as
anaemia is not considered a disease in itself but rather a
sign of a range of underlying conditions, the underlying
cause is often under-diagnosed [26, 27]. Besides an an-
amnesis and physical examination, (a range of) labora-
tory tests are essential in the diagnostic work-up [28,
29]. The Dutch College of General Practitioners
(DCGP)-guideline provides a flowchart supporting GPs
in deciding which tests to order based on patient’s symp-
toms, their medical history, and the clinical suspicion
[28]. The tests included in this flowchart include C-
reactive protein (CRP), creatinine, erythrocyte sedimen-
tation rate (ESR), ferritin, folic acid, haemoglobin, lactate
dehydrogenase, leukocytes, mean corpuscular volume
(MCV), reticulocytes, serum iron, thrombocytes, trans-
ferrin and vitamin B12. Besides these 14 tests, the pa-
tient’s renal function (i.e. the eGFR [or MDRD]) is
calculated, serving as 15th test result.
Despite following the DCGP-guideline, the underlying
cause of anaemia remains unknown in 52% of patients
[30]. Previous research indicated that immediately order-
ing all 15 tests in anaemia patients improves GPs’ ability
to correctly diagnose the underlying cause and is cost-
effective compared to letting GPs decide themselves
which tests to order [31, 32]. It is however unknown
whether all 15 tests individually contribute to the GP’s
ability to (correctly) diagnose the underlying cause of an-
aemia. Therefore, the current study investigates to what
extent each individual test (within the full set of 15 tests)
adds value to this diagnostic process. In addition, the op-




The data used for this analysis were obtained from a
previously conducted questionnaire, in which GPs were
asked to determine the underlying cause in cases of real-
world anaemia patients. In this section, an explanation
of the questionnaire and the database used in this ques-
tionnaire will be provided. A more extensive description
was published previously [31].
The cases used in this questionnaire were obtained
from a prospective database including patients aged ≥50
years presenting with newly diagnosed anaemia in gen-
eral practice (n = 2389). This database excluded patients
with multiple underlying causes (n = 293) and contained
information about patients’ age, gender, and the results
of all abovementioned 15 tests. From this database, 201
cases were randomly selected to be used in the question-
naire. In this random selection, the actual prevalence of
each of the underlying causes of anaemia was main-
tained [32]. The characteristics of the 201 cases used in
this questionnaire are presented in Table 1. In the ques-
tionnaire, GPs (n = 139) were presented with cases of
anaemia patients. For each GP, six cases of anaemia pa-
tients were randomly drawn from the set of 201 cases.
For each of these six cases, the GP was asked to establish
the underlying cause based on the patient’s age, gender,
and test results. In three out of these six cases, GPs were
immediately provided with all 15 test results. In the
other three cases, GPs were asked to decide for them-
selves which tests to perform. These questions were
however excluded from the current analysis as this ana-
lysis only focused on the three cases in which the GP re-
ceived the full set of 15 test results. The underlying
causes to choose from were anaemia of chronic disease
(ACD), iron deficiency anaemia (IDA) and renal anaemia
(RA). In addition, GPs could choose the option ‘other’ in
which they were asked to specify the expected under-
lying cause of anaemia, or they could indicate that they
could not establish the underlying cause based on the in-
formation provided (classified as ‘unknown’). For each
case, the correctness of this underlying cause was deter-
mined by comparing it with its (presumably) correct
diagnosis as established by an expert panel, consisting of
a GP, an internist and a clinical chemist [31].
Altogether, the questionnaire resulted in 378 anaemia
cases in whom an underlying cause was diagnosed by a
GP based on the full set of 15 test results. An overview
of the entire process of case selection and presenting
these to the GPs is shown in Fig. 1.
Data analysis
The data obtained from the 378 cases, including the re-
sults of the 15 test for each case, the underlying cause of
anaemia as indicated by the GP, as well as the correct
underlying cause according to the expert panel, were
used as input for the current analysis. Data were ana-
lyzed using R (version 3.5.0) [33]. The package mice
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(version 3.30) was used for single regression imputation
of missing data for the ESR test (n = 20) [34].
As it was considered unlikely that other, less common,
causes of anaemia can be diagnosed in general practice
(based on the limited information provided) [31], this
study specifically focused on correctly diagnosing IDA,
ACD and RA. Therefore, the diagnoses ‘other’ and ‘un-
known’ were considered as one category. For CRP and
vitamin B12, the non-numerical values “smaller than 5
mg/L” (n = 109) and “smaller than 111 pmol/L” (n = 2)
were replaced by the numerical values 4 mg/L and 110
pmol/L, respectively.
For patients with anaemia, the majority of the 15 tests
analyzed in this study have one single cut-off value to in-
dicate abnormal test results, for example a haemoglobin
level < 8.5 mmol/L (i.e. < 13.7 g/dL) in male patients.
These test results were therefore handled as binary vari-
ables (i.e. normal/abnormal). However, five tests (i.e. fer-
ritin, leukocytes, MCV, thrombocytes and transferrin)
can have a too low as well as a too high test result. As
too low and too high values are often indicative of
different underlying causes of anaemia, the numerical
values of these five tests were converted to categorical
results. A detailed overview of the cut-off values used
(based on the DCGP-guideline [28]) is provided in Table
S1 of Additional file 1.
The value of individual tests for (correctly) diagnosing an
underlying cause of anaemia
The impact on the GPs’ ability to diagnose an underlying
cause of anaemia was investigated in two ways: 1) for
diagnosing an underlying cause of anaemia (regardless
whether this diagnosis was correct), 2) for diagnosing
the correct underlying cause of anaemia. For investigat-
ing the impact of an individual test result on GPs’ ability
to diagnose an underlying cause, the impact of each of
the 15 tests (within this complete set of tests) was
assessed separately by fitting a multinomial logistic re-
gression model (MLR) with a logistic link function, using
the mlogit-package and nnet-package [35, 36]. In
addition to the 15 test results, the patients’ age and gen-
der were also considered as predictors in the fitting
Table 1 Descriptive statistics. Descriptive statistics of test results
Mean SD Range Normal, % (n) Abnormal, % (n)
Tests with numerical results: mean, SD, and frequency of result within reference valuea (n = 201 cases)
ESR (mm/h) 34.7 27.3 0.0–120.0 60% (120) 40% (81)
CRP (mg/L) 26.5 46.9 4.0–290.0 67% (135) 33% (66)
Haemoglobin (mmol/L) 7.3 0.8 4.2–8.4 0% (0) 100% (201)
Reticulocytes (% of RBCs) 1.0 0.5 0.3–4.8 98% (197) 2% (4)
Creatinine (μmol/L) 91.5 49.4 42.0–449.0 67% (135) Low: 3% [6];
High: 30% (60)
eGFR (mL/min/1,73m2) 71.0 25.8 8.0–184.0 62% (124) 38% (77)
LDH (E/L) 399.5 652.7 126.0–9385.0 84% (169) 16% (32)
Serum iron (μmol/L) 10.1 5.3 1.9–25.4 36% (73) 64% (128)
Folic acid (nmol/L) 21.6 20.1 3.0–227.0 98% (197) 2% (4)
Vitamin B12 (pmol/L) 335.1 182.6 102.0–1408.0 97% (195) 3% (6)
Tests with categorical results: frequency of result within reference valuea (n = 201 cases)
Ferritin (μg/L) 196.6 316.5 2.0–3322.0 Low normal: 35% (70)
High normal: 24% (49)
Low: 13% (25)
High: 29% (57)
Leukocytes (× 109/L) 7.7 3.1 2.0–25.3 78% (157) Low: 6% (13)
High 15% (31)
Thrombocytes (× 109/L) 295.5 107.9 117.0–782.0 82% (165) Low: 2% (5)
High: 15% (31)
MCV (fL) 90.0 8.3 60.0–130.0 84% (168) Low: 9% (18)
High: 8% (15)
Transferrin (g/L) 2.5 0.6 1.0–4.1 76% (152) Low: 18% (36)
High: 6% (13)
CRP C-reactive protein, eGFR estimated glomerular filtration rate, ESR erythrocyte sedimentation rate, LDH lactate dehydrogenase, MCV mean corpuscular volume,
RBCs red blood cells, SD standard deviation
aReference values applied in the Albert Schweitzer Hospital were used to determine whether a test result was normal or abnormal
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process. The MLR shows the impact of a one unit
change in the predictor (for example a change in ESR
from 35 to 36 mm/h) on the log odds of the GP diagnos-
ing a specific cause of anaemia rather than diagnosing
‘unknown’. The goal of this analysis was to assess
whether specific test outcomes may substantially affect
the likelihood of diagnosing one specific underlying
cause of anaemia, while not affecting the diagnosis of
any of the other underlying causes. In other words, it is
determined whether the GPs incorporate this test in
their decision to diagnose a specific underlying cause of
anaemia.
Subsequently, the added value of each test (within the
complete set of tests) on the GP’s ability to diagnose the
correct underlying cause was assessed by fitting a bino-
mial logistic regression model (BLR). In contrast to the
MLR, the BLR shows the impact of a one unit change in
test result on the log odds of the GP diagnosing the cor-
rect rather than an incorrect underlying cause (for details
see Additional file 1).
The combined value of tests for (correctly) diagnosing an
underlying cause of anaemia
In current practice, many of the 15 tests are ordered
simultaneously [31]. However, an overlap may exist
between the information they provide and hence their
impact on the GP’s ability to (correctly) diagnose the
underlying cause. Consequently, a subset of tests may ac-
tually suffice. Yet, this overlap cannot be captured using
a single MLR or BLR model, because the added value of
a test may depend on the availability of other test results.
Therefore, this overlap was determined, and (largely) re-
moved, by identifying the statistically most efficient test
subset (i.e. best subset) using stepwise backward selec-
tion [37]. This analysis was performed twice: with and
without considering the correctness of the diagnosed
underlying cause. The Akaike Information Criterion
(AIC) was used as performance indicator to balance
model complexity (i.e. number of predictors) and
goodness-of-fit of the model [38]. In this process, the
initial set of 17 predictors (i.e. age, gender and 15 test re-
sults) was iteratively reduced by removing the predictor
with the lowest impact on the ability of the GP to (cor-
rectly) diagnose the underlying cause of anaemia. During
each iteration, the AIC was determined, with the subset
model with the lowest AIC being the most favorable.
This process was repeated until the AIC could not be
decreased further (Fig. 2), indicating that reducing model
complexity by removing one more predictor resulted in
substantially worse performance.
Fig. 1 Overview of case selection and cases presented in questionnaire. This figure presents an overview of how the cases were selected from
the database and presented to the GPs who participated in the questionnaire. *125 GPs completed all 3 cases, 1 GP completed only 2 cases and
1 GP completed only 1 case. ACD = anaemia of chronic disease, GP = general practitioner, IDA = iron deficiency anaemia, RA = renal anaemia
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Testing assumptions
Finally, several assumptions underlying the logistic re-
gression model were tested, including testing for multi-
collinearity, perfect separation of predictors, and a
Hausman-McFadden test (for details see Additional file
1).
This research did not receive any specific grant from
funding agencies in the public, commercial, or not-for-
profit sectors.
Results
As mentioned previously, the questionnaire resulted in
378 anaemia cases that were included in the current
analysis. Of these cases, 117 (31.0%) were diagnosed as
ACD, 76 (20.1%) as IDA, 50 (13.2%) as RA, 22 (5.8%) as
‘other’ and 113 (29.9%) as ‘unknown’. Comparing these
diagnoses with the diagnoses by the expert panel indi-
cated that 234 (61.9%) were correct, including 47
(61.8%) of the IDA diagnoses, 73 (62.4%) of the ACD
diagnoses, 29 (58.0%) of the RA diagnoses, 17 (77.3%) of
the ‘other underlying causes’ and 68 (60.2%) of the
‘unknown’.
These 378 cases were based on 201 cases of anaemia
patients, indicating that some cases were answered mul-
tiple times (by different GPs). Of these 201 patients, 94
(47%) were male, 107 (53%) were female, and the mean
age was 74.7 years (range: 50–102 years).
The value of individual tests for (correctly) diagnosing an
underlying cause of anaemia
When considering the impact of individual test results
within the complete set of tests, the MLR indicates that
CRP, ESR, ferritin, folic acid, leukocytes, eGFR, reticulo-
cytes and serum iron significantly impact the ability of
the GP to diagnose an underlying cause of anaemia (in-
stead of ‘unknown’), regardless whether this diagnosis is
correct, as shown in Table 2. Each row in Table 2 indi-
cates the effect of a change in the test result on the
probability that the GP diagnoses a specific underlying
cause, rather than diagnosing an ‘unknown’ cause. For
the tests with numerical results (i.e. ESR, eGFR, folic
acid, reticulocytes and serum iron), this ‘change’ implies
a one unit shift in the test result, for example a shift in
ESR from 36 to 35mm/h. For the categorized test re-
sults, the table mentions the specific shift in the result
Fig. 2 Overview of the best subset selection process. This figure illustrates the steps taken in selecting the best (i.e. statistically most efficient)
subset of laboratory tests. AIC = Akaike Information Criterion
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category (i.e. from normal to abnormal for leukocytes,
and a shift from low normal to either low, high normal,
or to high, for ferritin). The results of the other seven
tests (i.e. creatinine, CRP, haemoglobin, LDH, MCV,
thrombocytes, transferrin and vitamin B12) do not sig-
nificantly contribute to the ability of the GP to diagnose
an underlying cause. In other words, the extent to which
the GP considers this test result in diagnosing an under-
lying cause of anaemia is insufficient to have a statisti-
cally significant impact. As this analysis involves many
different comparisons, only the significant outcomes are
shown in this table.
Table 3 shows the results of the BLR, indicating the
impact of a change in the result of the individual tests,
within the complete set of tests, on the ability of the GP
to diagnose the correct underlying cause of anaemia. Re-
sults indicate a statistically significant impact for a shift
from a normal to a high MCV, as well as a shift from a
low normal to a high normal ferritin level, and from a
low normal to low ferritin level. For the other tests with
categorical results (i.e. leukocytes, thrombocytes, and
transferrin), as well as all tests with numerical results
(i.e. creatinine, CRP, eGFR, ESR, folic acid, haemoglobin,
LDH, serum iron and vitamin B12) no significant impact
of a one unit change in a single test result on the ability
of the GP to correctly diagnose the underlying cause of
anaemia was found.
The combined value of tests for (correctly) diagnosing an
underlying cause of anaemia
When considering the value of a combination of test re-
sults, the most efficient test subset for diagnosing an
underlying cause as well as for diagnosing the correct
underlying cause are shown (Table 4). For diagnosing an
underlying cause, seven predictors were eliminated from
the initial set of 17 predictors (i.e. age, gender and the
15 test results). The 10 remaining predictors include the
patient characteristic ‘age’, and the tests CRP, ESR,
Table 2 Impact of laboratory tests on diagnose an underlying cause of anaemia by GPs. This table shows the impact of individual
test results (within the complete set of tests) on the ability of the GP to diagnose an underlying cause of anaemia, regardless
whether this diagnosis is correct
Tests with numerical results







ESR ACD 0.031 1.032 <
0.001***
ESR RA −0.044 0.957 0.047*
ESR Other −0.060 0.941 0.022*
CRP RA −0.065 0.937 0.043*
Reticulocytes Other 3.650 38.471 <
0.001***
eGFR RA −0.250 0.779 <
0.001***
Folic acid Other −0.091 0.913 0.023*
Serum iron IDA −0.158 0.854 0.024*
Tests with categorical results







Leukocytes Normal to abnormal Other 2.352 10.503 0.005**
Ferritin Low normal to low IDA 3.049 21.088 <
0.001***
Ferritin Low normal to high
normal
ACD 1.310 3.706 0.003**
Ferritin Low normal to high
normal
IDA 1.364 3.911 0.031*
Ferritin Low normal to high ACD 1.026 2.791 0.014*
Ferritin Low normal to high IDA 1.469 4.343 0.029*
Ferritin Low normal to high Other −4.690 0.009 0.002**
ACD anaemia of chronic disease, CRP C-reactive protein, eGFR estimated glomerular filtration rate, ESR erythrocyte sedimentation rate, IDA iron deficiency anaemia,
RA renal anaemia
Significance levels: *** = 0.001; ** = 0.01; * = 0.05
aFor a more detailed explanation on the interpretation of the values reported in this table, see Additional file 1
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ferritin, folic acid, haemoglobin, leukocytes, eGFR, retic-
ulocytes and serum iron. For diagnosing the correct
underlying cause, 11 predictors were eliminated. The six
remaining predictors include the patient characteristic
‘age’ and the tests CRP, ferritin, folic acid, MCV and
transferrin. For details see Tables S2 and S3 of Add-
itional file 1.
Testing assumptions
All variance inflation factors determined were < 5 (Table
S4 of Additional file 1), all maximum likelihood estima-
tors converged, and the independence of irrelevant alter-
natives assumption was not rejected.
Discussion
Of the 15 tests evaluated, only a subset impacts the GP’s
ability to (correctly) diagnose an underlying cause of an-
aemia, from a statistical perspective. The statistically
most efficient subset of predictors for diagnosing the
correct underlying cause contains, besides a patient’s age,
five tests: ferritin, CRP, MCV, transferrin and folic acid.
However, when considering predictors for diagnosing
an underlying cause of anaemia, the statistically most ef-
ficient subset contains, besides a patient’s age, nine tests
(i.e. CRP, ESR, ferritin, folic acid, haemoglobin, leuko-
cytes, eGFR, reticulocytes and serum iron). For some of
these tests, a strong relation may exist between the test
outcome and the probability that the GP diagnoses a
specific underlying cause, regardless of whether this
underlying cause is correct. In other words, when tests
contribute to diagnosing an underlying cause by the GP
(as shown in Table 2), it implies that these tests are
taken into account by the GP in their decision making
process. However, this does not imply that the test also
has a (statistically significant) impact on diagnosing the
correct underlying cause (as shown in Table 3). For ex-
ample, a high ESR is often, but not always, caused by
ACD [28]. Therefore, an elevated ESR test result might
lead (too often) to this particular diagnosis, also if it is
incorrect.
As shown in Table 4, the most efficient subset for
diagnosing an underlying cause of anaemia includes the
Table 3 Impact of laboratory tests on diagnosing the correct underlying cause of anaemia by GPs. This table shows the impact of
individual test results (within the complete set of tests) on the ability of the GP to diagnose the correct underlying cause of anaemia
Tests with numerical results
Test Coefficient (log oddsa) Exponentiated coefficient (odds) p-value
ESR −0.004 0.996 0.578
CRP 0.008 1.008 0.070
Haemoglobin −0.216 0.806 0.395
Reticulocytes 0.176 0.192 0.560
Creatinine 0.006 1.006 0.222
eGFR 0.015 1.015 0.094
LDH 0.000 1.001 0.641
Serum iron 0.024 1.024 0.482
Folic acid 0.013 1.014 0.075
Vitamin B12 −0.000 1.000 0.509
Tests with categorical results
Test Shift in the result category Coefficient (log oddsa) Exponentiated coefficient (odds) p-value
MCV Normal to high 1.600 4.954 0.006 **
MCV Normal to low −0.176 0.838 0.785
Ferritin Low normal to high −0.123 0.884 0.725
Ferritin Low normal to high normal −0.634 0.531 0.047 *
Ferritin Low normal to low 1.231 3.425 0.030 *
Leukocytes Normal to abnormal −0.169 0.844 0.584
Thrombocytes Normal to abnormal 0.126 1.134 0.730
Transferrin Normal to high 0.246 1.279 0.741
Transferrin Normal to low −0.781 0.458 0.051
CRP C-reactive protein, eGFR estimated glomerular filtration rate, ESR erythrocyte sedimentation rate, LDH lactate dehydrogenase, MCV mean corpuscular volume
Significance levels: *** = 0.001; ** = 0.01; * = 0.05
aFor a more detailed explanation on the interpretation of the values reported in this table, see Additional file 1
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haemoglobin test, whereas the most efficient subset for
diagnosing a correct underlying cause does not. This
may be explained by the fact that a low haemoglobin
level is a prerequisite for diagnosing anaemia without
providing evidence on the underlying cause.
When considering the results of the BLR for individ-
ual tests, it is observed that only two of the statistically
significant tests (i.e. ferritin and MCV) were found to
also be part of the statistically most efficient subset, that
is combination of tests, for diagnosing the correct under-
lying cause of anaemia. The other three tests in this sub-
set (i.e. CRP, transferrin and folic acid) were not
statistically significant when considered individually.
This is most likely explained by the fact that these tests,
in combination, are highly important for the GP to diag-
nose the correct underlying cause.
Besides the cases in whom the GPs and/or the expert
panel were able to (correctly) diagnose an underlying
cause of anaemia, an underlying cause could not be
established in 113 out of 378 (i.e. 29.9%) of the cases by
the GPs, and 63 out of 201 cases (i.e. 31.3%) by the ex-
pert panel, which is in line with literature [21, 39–41].
Further details on the suggested clinical management by
the GPs (including medication prescriptions, referral to
secondary care, etc.) was published previously [32].
Strengths
As the analyses in this study are based on real-life patient
data (in which the incidence of the underlying causes of
anaemia mimics current practice) and because a represen-
tative sample of GPs responded to the survey [31, 32], the
results likely provide a good representation of current
practice. In addition, the incorporation of a patient’s age
and gender as predictors further increases the reliability of
the results, as these characteristics should be considered
in a patient’s diagnostic work-up [28].
Limitations
This study has certain limitations. First, although the
GPs were provided with the patients’ age and gender,
they should ideally also have been able to incorporate in-
formation about a patient’s anamnesis, medical history,
physical examination, or the results of other diagnostic
tests, in their diagnostic process [28]. For example, as-
pects like a history of renal failure may be highly import-
ant for diagnosing RA. However, as such aspects are
(partly) dependent on the GP’s perception and experi-
ence, these cannot be comprehensively captured in a
database. As both the GPs and the expert panel estab-
lished the underlying cause of anaemia based on the
(limited) information presented in the questionnaire and
Table 4 Result of best subset selection. This table shows the result of best subset (i.e. most efficient subset) selection for the two
patient characteristics and the 15 test results, for diagnosing an underlying cause as well as for diagnosing the correct underlying
cause
Predictors included after best subset selection
Predictors For diagnosing an underlying cause For diagnosing the correct underlying cause

















CRP C-reactive protein, eGFR estimated glomerular filtration rate, ESR erythrocyte sedimentation rate, LDH lactate dehydrogenase, MCV mean corpuscular volume
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by using the available guidelines [28], this lack of infor-
mation was similar in both groups. As a consequence,
the underlying causes diagnosed in the questionnaire
may not fully resemble the diagnosis that would have
been established in clinical practice, but this effect is
likely similar for GPs and the expert panel. It is therefore
expected that this limitation did not affect the added
value of the 15 tests as reported in this study. In
addition, as the expert panel (i.e. a GP, an internist and
a clinical chemist) established the underlying cause
based on their broad expertise across these three disci-
plines, and because they used the current clinical guide-
lines, it was assumed that this diagnosis was correct or
at least the best diagnosis that could be established
based on the information provided.
Second, the analysis only considers the impact of la-
boratory tests on the ability of GPs to (correctly) diag-
nose the underlying cause of anaemia, and does not
account for other aspects of the value of testing (e.g. in
terms of patient reassurance). Third, the impact of indi-
vidual tests on setting a diagnosis or a correct diagnosis
is expressed in terms of a one unit change in the result
of a single test. The expected variability in test results
should therefore be considered in relation to its unit of
measurement. For example, the reticulocyte test result
usually varies between 1 and 2% [42], indicating that a
one unit (i.e. 1%) change leads to a very high regression
coefficient compared to a one unit (i.e. 1 mm/h) change
in ESR. The difference in the impact of these changes in
clinical practice is however likely less pronounced. In
addition, in the current analysis, all numerical test re-
sults were classified as either normal or abnormal. Con-
sequently, the analysis could not account for the
potential impact of test results that deviate strongly from
their reference value, compared with test results that
only show a minor deviation, on the (correctness) of the
diagnosed underlying cause. Finally, tests were evaluated
and selected based on their overall contribution to the
GP’s ability to correctly diagnose the underlying cause of
anaemia. Consequently, tests that may only be valuable
for diagnosing a specific (less common) cause may not
be identified as such in the current analysis, where
added value is essentially assessed across all patients and
all underlying causes. This may (for example) explain
why an abnormal creatinine test result was not signifi-
cantly associated with (correctly) diagnosing RA, as only
26 out of 201 cases (12.9%) involved RA patients.
Implications for practice
Annually, in the Netherlands, 57,000 patients are newly
diagnosed with anaemia in general practice [31]. Com-
pared to immediately ordering the full set of 15 tests,
test overuse may be reduced with 67% while the percent-
age of correct diagnoses is expected to be (almost)
unaffected. In practice in the Netherlands, GPs may (ini-
tially) order any number of tests, and on average they
order seven tests [31]. Conversely, ordering just the five
tests of the statistically most efficient subset, and order-
ing additional tests only when no clear underlying cause
can be found based on this, could save up to two tests
per patient (i.e. -29%) [32], while the percentage of pa-
tients with a correct diagnosis is expected to increase.
Although cost savings in terms of preventing (unneces-
sary) laboratory tests are relatively small, the most effi-
cient test subset may prevent unnecessary downstream
diagnostic activities, thereby preventing unnecessary pa-
tient burden and reducing healthcare costs. However,
decisions regarding which tests to perform in (sus-
pected) anaemia patients are increasingly supported by
clinical chemistry laboratories [43]. As the protocols for
this ‘reflex-testing’ differ between hospitals, the results of
this study are likely also valuable for laboratories to es-
tablish a standardized, optimal subset of laboratory tests
for reflex-testing. As the work-up of establishing the
underlying cause in newly diagnosed anaemia patients
differs (slightly) between countries, this may limit the
generalizability of the results presented here. The con-
cept of overuse of laboratory tests is, however, not lim-
ited to the Netherlands and also not limited to anaemia
patients. This study can therefore be considered an ex-
ample of how statistical analyses can contribute to defin-
ing a potentially more efficient subset of laboratory tests
and thereby to prevent test overuse. It is therefore rec-
ommended to perform similar studies in other countries,
disease areas or medical conditions, in order to safely
decrease the number of tests performed.
Conclusions
Although current clinical guidelines recommend the use
of an extensive set of laboratory tests to diagnose the
underlying cause of anaemia, a subset of five tests has
most added value from a statistical perspective. This
subsets still provides a similar ability to the GP to (cor-
rectly) diagnose an underlying cause of anaemia. Conse-
quently, a statistical approach to assessing the added
value of tests may reduce test overuse. Whether such a
subset of tests is acceptable and cost-effective in daily
practice should be further investigated.
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